Status:

COMPLETED

Characterizing Protein Biomarkers of Post-infection Irritable Bowel Syndrome

Lead Sponsor:

University of Nevada, Reno

Conditions:

Post-infectious Irritable Bowel Syndrome

Irritable Bowel Syndrome

Eligibility:

All Genders

18-100 years

Brief Summary

The investigators will characterize and compare protein signatures between groups with and without post-infection irritable bowel syndrome (PI-IBS). From previous Healthy Nevada Project (HNP) particip...

Detailed Description

The investigators will characterize and compare protein signatures between groups with and without PI-IBS. From previous HNP participants, at least 60 patients with PI-IBS and 60 healthy controls will...

Eligibility Criteria

Inclusion

  • Participants must have a Healthy Nevada Project record and linked Renown Health medical record
  • Must be between 18 and 89 years of age
  • Must have previously consented to being contacted and have updated contact information

Exclusion

  • None

Key Trial Info

Start Date :

April 11 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 30 2024

Estimated Enrollment :

81 Patients enrolled

Trial Details

Trial ID

NCT06032117

Start Date

April 11 2024

End Date

December 30 2024

Last Update

April 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Renow Health, Mae Anne Clinic

Reno, Nevada, United States, 89523